Canopy Clinical Altona North

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials
• Atopic dermatitis (eczema)1 trial
• Type 2 diabetes1 trial

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Recruiting3 trials
• Active, not recruiting1 trial

Lead sponsor

• Amgen2 trials
• Alphyn Biologics1 trial
• Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.1 trial

Running trials

• Recruiting

  Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  NCT07684235· Phase 3· Amgen· Source

• Recruiting

  The Efficacy and Safety of Efsubaglutide Alfa in Overweight/Obesity（SPARKLE）

  NCT07114419· Phase 2· Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.· Source

  Contact: Oscar Walsh

• Recruiting

  Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.

  NCT06855745· Phase 2· Alphyn Biologics· Source

  Contact: Dr Oscar Walsh

• Active, not recruiting

  Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

  NCT06858839· Phase 3· Amgen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity2 recruiting
• Atopic dermatitis (eczema)1 recruiting